| Revenue | |
| General and administrative | 480.02K |
| Research and development | 280.24K |
| Total operating expenses | 2.21M |
| Loss from operations | -2.21M |
| Grant income | |
| Fair value - warrant liability | |
| Sale of state income tax loss - net | |
| Other noncash (expense) income, net | |
| Loss on extinguishment of debt | |
| Write-off of patents abandoned | |
| Amortization of debt discount and financing costs | |
| Interest expense - convertible notes | |
| Interest (expense) income - net | -74 |
| Net loss | -933.58K |
| Preferred dividends | -9.5K |
| Loss applicable to common shares | -943.08K |
| Basic and diluted net loss per common share | -0.05 |
| Basic and diluted weighted-average number of common shares outstanding | |